KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) FCF Margin (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed FCF Margin for 8 consecutive years, with 3.09% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 3203.0% to 3.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 16.79% through Dec 2025, up 3713.0% year-over-year, with the annual reading at 16.79% for FY2025, 3713.0% up from the prior year.
  • FCF Margin hit 3.09% in Q4 2025 for Adaptive Biotechnologies, up from 6.26% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 3.09% in Q4 2025 to a low of 370.47% in Q2 2023.
  • Historically, FCF Margin has averaged 105.41% across 5 years, with a median of 91.24% in 2022.
  • Biggest five-year swings in FCF Margin: crashed -26190bps in 2023 and later surged 33317bps in 2024.
  • Year by year, FCF Margin stood at 166.28% in 2021, then surged by 68bps to 52.75% in 2022, then fell by -17bps to 61.66% in 2023, then skyrocketed by 53bps to 28.94% in 2024, then soared by 111bps to 3.09% in 2025.
  • Business Quant data shows FCF Margin for ADPT at 3.09% in Q4 2025, 6.26% in Q3 2025, and 24.0% in Q2 2025.